Company: ERAS
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042682
Chunk: 103

Company: Erasca, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 16
Chunk 103
---

    22,500

    —

    Accretion on marketable securities, net

    (9,590
    )

    (6,951
    )

    Impairment charge on operating lease assets and property and equipment

    4,653

    —

    Impairment charge on investment in equity securities

    2,157

    —

    Changes in operating assets and liabilities:

          Prepaid expenses and other current and long-term assets

    (2,397
    )

    939

          Accounts payable

    (1,532
    )

    (886
    )

          Accrued expenses and other current and long-term liabilities

    6,396

    (2,301
    )

          Operating lease assets and liabilities, net

    (732
    )

    3,061

    Net cash used in operating activities

    (109,417
    )

    (101,217
    )

    Cash flows from investing activities:

    Purchases of marketable securities

    (403,224
    )

    (314,390
    )

    Maturities of marketable securities

    269,325

    244,945

    In-process research and development

    (22,500
    )

    (20,000
    )

    Payment made for investment in equity securities

    (157
    )

    —

    Purchases of property and equipment

    (60
    )

    (1,775
    )

    Net cash used in investing activities

    (156,616
    )

    (91,220
    )

    Cash flows from financing activities:

    Proceeds from issuance of common stock in private placement, net of fees and expenses

    43,604

    —

    Proceeds from issuance of common stock in underwritten offering, net of discounts and offering costs

    174,426

    —

    Proceeds from issuance of common stock in ATM Offering, net of commissions and expenses

    21,031

    —

    Proceeds from the exercise of stock options

    836

    505

    Proceeds from issuance of common stock under the Employee Stock Purchase Plan

    800

    790

    Net cash provided by financing activities

    240,697

    1,295

    Net decrease in cash, cash equivalents and restricted cash

    (25